PTGS2 and neoplasm: The upregulation of COX-2 by a variety of factors, including cytokines and growth factors, and the resulting increase in prostaglandin E2 (PGE2) levels may promote chronic inflammatory conditions, thus initiating tumor development [1,2,3].